Smith & Nephew PLC
SN.
Company Profile
Business description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Contact
Hatters Lane
Building 5, Croxley Park
WatfordHertfordshireWD18 8YE
GBRT: +44 1923477100
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
17,349
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,133.10 | 6.20 | 0.08% |
CAC 40 | 7,804.63 | 71.73 | -0.91% |
DAX 40 | 22,189.46 | 350.52 | -1.56% |
Dow JONES (US) | 41,989.96 | 11.80 | -0.03% |
FTSE 100 | 8,566.35 | 68.45 | -0.79% |
HKSE | 23,202.53 | 4.31 | -0.02% |
NASDAQ | 17,449.89 | 150.60 | 0.87% |
Nikkei 225 | 35,725.87 | 101.39 | 0.28% |
NZX 50 Index | 12,320.19 | 7.59 | 0.06% |
S&P 500 | 5,633.07 | 21.22 | 0.38% |
S&P/ASX 200 | 7,934.50 | 9.30 | 0.12% |
SSE Composite Index | 3,350.13 | 1.69 | 0.05% |